April 19, 2014

A Controlled Trial of Renal Denervation for Resistant Hypertension

.   .   

The SYMPLICITY HTN-3 trial did not show a significant reduction of systolic blood pressure in patients with resistant hypertension 6 months after renal-artery denervation as compared with a sham control.

Related Articles:

Clinical Trial Results, Hypertension